Am Heart J

1. AVIDAN Y, Naoum I, Weizman B, Mizrachi O, et al
   Determinants of post-discharge LDL-C testing and target attainment after acute coronary syndrome: a 10-year population-based study.
   Am Heart J. 2026 Sep 11:107607. doi: 10.1016/j.ahj.2026.107607.
   

   >> Share

   
   

   
   Am J Cardiol

2. CHI G, Gibson CM, Coller BS, Granger CB, et al
   Efficacy and Safety of Zalunfiban by Creatinine Clearance Among Patients with ST-Elevation Myocardial Infarction: Analysis from the CELEBRATE Trial.
   Am J Cardiol. 2026 Sep 11:S0002-9149(26)00574.
   

   >> Share

   
   
3. FAROOQ M, Safiullah M, Hayat MS, Arshad MA, et al
   Burden of Ischemic Heart Disease and its attributable risk factors from 1990 to 2021, and forecasts till 2050: A comparative analysis of Low versus High Socio-demographic Index (SDI) Regions.
   Am J Cardiol. 2026 Sep 9:S0002-9149(26)00568.
   

   >> Share

   
   
4. NASIFOV M, Polat F, Seferova V, Jafarov P, et al
   Procedural Characteristics and Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With and Without Prior CABG.
   Am J Cardiol. 2026 Sep 11:S0002-9149(26)00566.
   

   >> Share

   
   
5. BCHARAH H, Ibrahim R, Bcharah G, Hafez A, et al
   Predictors of Perioperative Major Adverse Cardiovascular Events After Bariatric Surgery.
   Am J Cardiol. 2026 Sep 11:S0002-9149(26)00569.
   

   >> Share

   
   
6. KUMAR S, Subramaniam A, Thotakura S, Kearney KE, et al
   Prognostic Implications of Academic Research Consortium-High Bleeding Risk Criteria in Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention.
   Am J Cardiol. 2026 Sep 7:S0002-9149(26)00570.
   

   >> Share

   
   
7. BUCKLEY K, Ortiz L, Stowers C, Hawk F, et al
   Impact of Confirmatory Invasive Coronary Function Testing on Seattle Angina Questionnaire-7 Scores in Patients with Angina and Nonobstructive Coronary Arteries.
   Am J Cardiol. 2026 Sep 5:S0002-9149(26)00553.
   

   >> Share

   
   

   
   Am J Emerg Med

8. TOOLE S, Bishop R, Acquisto NM, Jones CMC, et al
   Safety and efficacy of tenecteplase versus alteplase for acute ischemic stroke in a real-world patient population.
   Am J Emerg Med. 2026;110:315-319.
   

   >> Share

   
   

   
   Angiology

9. ZHANG Y, Bai J
   Exploring the Potential Role of SLC25A25-AS1 in Acute Coronary Syndrome.
   Angiology. 2026 Sep 10:33197261489649. doi: 10.1177/00033197261489649.
   

   >> Share

   
   

   
   BMJ

10. LIANG J, Choi Y, Shen P, Wells S, et al
    Simultaneous derivation, validation, and comparison of predictor hazard ratios for cardiovascular risk prediction equations in patients with diabetes from high versus non-high income countries: cohort study.
    BMJ. 2026;394:e100535.
    

    >> Share

    
    

    
    Br J Haematol

11. BELLICINI MG
    Troponin elevation and myocardial infarction in patients with haematological disorders.
    Br J Haematol. 2026 Sep 6. doi: 10.1111/bjh.70833.
    

    >> Share

    
    
12. COSTA A, Mulas O, Pilo F, Atzeni E, et al
    Estimated pulse wave velocity as a marker of major adverse cardiovascular events in essential thrombocythaemia and polycythaemia vera.
    Br J Haematol. 2026 Sep 8. doi: 10.1111/bjh.70820.
    

    >> Share

    
    

    
    Can J Cardiol

13. AKMAN C, Tanik VO, Guner A, Serin E, et al
    Crossover Versus Ostial Single-stent Implantation for Ostial Left Circumflex Artery Lesions: The Multicenter CROSS-LCX Registry.
    Can J Cardiol. 2026;42:1974-1986.
    

    >> Share

    
    

    
    Catheter Cardiovasc Interv

14. HUANG D, Yang X, Zhang X, Huang X, et al
    Balancing Thrombosis and Bleeding: A Case Report of Acute Myocardial Infarction in an Elderly Patient With Hemophilia A.
    Catheter Cardiovasc Interv. 2026 Sep 7. doi: 10.1002/ccd.70858.
    

    >> Share

    
    
15. SHEN J, Wu Y, Wang B
    Acute Inferior Myocardial Infarction with Anomalous Origin of the Right Coronary Artery, Myocardial Bridging and Fibro-Lipid Plaque.
    Catheter Cardiovasc Interv. 2026 Sep 8. doi: 10.1002/ccd.70877.
    

    >> Share

    
    

    
    Circ Cardiovasc Interv

16. SUN Z, Du Y, Liu X, Yu H, et al
    Research Advances in Spontaneous Coronary Artery Dissection.
    Circ Cardiovasc Interv. 2026 Sep 9:e016831.
    

    >> Share

    
    

    
    Circ Res

17. HAYEK SS, Dryer SE
    Correction to: uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome.
    Circ Res. 2026;139:e000768.
    

    >> Share

    
    

    
    Circulation

18. CHEN S, Shen S, Su W, Fu L, et al
    HNRNPK Lactylation Amplifies Inflammation and Exacerbates Myocardial Ischemia/Reperfusion Injury by Regulating Jag2 Splicing.
    Circulation. 2026 Sep 8. doi: 10.1161/CIRCULATIONAHA.126.081410.
    

    >> Share

    
    
19. PURI K, Allen K, Jentzer J, Soderstrom R, et al
    Surviving Pediatric Cardiogenic Shock: Clinical Approach, Improving Outcomes, and Future Directions: A Scientific Statement From the American Heart Association.
    Circulation. 2026;154:e374-e392.
    

    >> Share

    
    
20. POWELL-WILEY TM
    Partnerships That Leverage Existing Community Strengths Are Key to Improving Cardiovascular Health.
    Circulation. 2026;154:876-878.
    

    >> Share

    
    
21. DE BAKKER M, Thurston AJF, Hammarsten O, Khachatryan M, et al
    Macrotroponin Complexes and Risk of Cardiovascular Events.
    Circulation. 2026 Sep 8. doi: 10.1161/CIRCULATIONAHA.126.080483.
    

    >> Share

    
    

    
    Clin Cardiol

22. SIEGERS CEP, Hoogervorst QP, Ramshorst JV, Boer SPM, et al
    Outcomes of an Interventional Approach in STEMI and NSTEMI All-Comer Octo and Nonagenarians.
    Clin Cardiol. 2026;49:e70463.
    

    >> Share

    
    

    
    Eur Heart J

23. MAY HT, Le VT, Anderson JL, Iverson L, et al
    Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial.
    Eur Heart J. 2026 Sep 7:ehag611. doi: 10.1093.
    

    >> Share

    
    
24. DAVIS JW, Manson JE
    More is not always better: vitamin D supplementation post-myocardial infarction in the Target-D trial.
    Eur Heart J. 2026 Sep 7:ehag672. doi: 10.1093.
    

    >> Share

    
    
25. LI S, Wang W, Zhou H, Zhang Y, et al
    Tropical cyclones and acute coronary syndromes: a Chinese nationwide study.
    Eur Heart J. 2026;47:4826-4838.
    

    >> Share

    
    

    
    Heart

26. CHOI Y, Kang DY, Kim H, Lee J, et al
    Role of routine surveillance stress testing in patients with or without imaging-guided or physiology-guided PCI.
    Heart. 2025 Oct 2:heartjnl-2025-326402. doi: 10.1136/heartjnl-2025-326402.
    

    >> Share

    
    
27. DEMANDT J, Sagel D, Camaro C, van Hattem VAE, et al
    Prehospital risk stratification in suspected non-ST-segment elevation acute coronary syndrome with point-of-care troponin: an individual patient data meta-analysis.
    Heart. 2026;112:1055-1062.
    

    >> Share

    
    

    
    Int J Cardiol

28. ISLETME A, Deveci S, Polat R, Ozkan BN, et al
    Tenascin-C differentiates obstructive from non-obstructive coronary artery disease in non-ST-elevation acute coronary syndrome.
    Int J Cardiol. 2026;463:134751.
    

    >> Share

    
    
29. MELISA S, Phuc PT, Chien SH, Chiang KH, et al
    Machine learning prediction of 30-day mortality in coronary artery disease: a retrospective multicenter study using electronic health records.
    Int J Cardiol. 2026;463:134745.
    

    >> Share

    
    
30. SCHIVALOCCHI M, Mazza R, Gaspardone C, Rigatelli A, et al
    NT-proBNP as a marker of coronary artery disease burden in chronic coronary syndromes.
    Int J Cardiol. 2026;463:134752.
    

    >> Share

    
    
31. GIOVACHINI L, Guedeney P, Zeitouni M, Rouanet S, et al
    Respective association with mortality of ischemic and haemorrhagic complications following percutaneous coronary intervention: insights from the FRANCE PCI registry.
    Int J Cardiol. 2026;463:134733.
    

    >> Share

    
    

    
    J Am Coll Cardiol

32. WANG Y, Zhu Y, Wang D
    Heterogeneous Value of a Multicondition Cardiovascular PRS Panel.
    J Am Coll Cardiol. 2026;88:e1513-e1514.
    

    >> Share

    
    
33. PATEL AP, Natarajan P
    REPLY: Heterogeneous Value of a Multicondition Cardiovascular PRS Panel.
    J Am Coll Cardiol. 2026;88:e1515.
    

    >> Share

    
    
34. BERRY ASF, Cawley D, Hattenberger A, Chang AR, et al
    Monogenic ALB Variants as Determinants of Severe Hypercholesterolemia: A Population-Based Cohort Study.
    J Am Coll Cardiol. 2026;88:1093-1103.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

35. BARBOSA LM, Rodrigues Oliveira VM, Nunes MDCP, Moreira HG, et al
    Direct Oral Anticoagulants versus Warfarin on Coronary Plaque in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    J Cardiovasc Pharmacol. 2025 Dec 16. doi: 10.1097/FJC.0000000000001787.
    

    >> Share

    
    
36. FILOMIA S, Del Buono MG, Saponara G, Aurigemma C, et al
    Fluoropyrimidine Cardiotoxicity: Role of Uridine Triacetate and Pharmacogenomic Insights from a Case of 5-FU-Induced Cardiogenic Shock.
    J Cardiovasc Pharmacol. 2026;88:216-222.
    

    >> Share

    
    

    
    J Clin Epidemiol

37. THIESMEIER R, Park JG, Patel SM, Murphy SA, et al
    Missing lactate values in critical care registries: a multiple imputation framework for cardiogenic shock research.
    J Clin Epidemiol. 2026;198:112426.
    

    >> Share

    
    

    
    J Electrocardiol

38. ASLANGER EK, Aggul B, Hamkan E, Inan D, et al
    Inferior ST-segment elevation in anterior myocardial infarction: Coronary anatomy and CMR-defined injury distribution-A pilot study.
    J Electrocardiol. 2026;99:154446.
    

    >> Share

    
    

    
    PLoS One

39. HEISIG J, Rink L, Gonschorek C, Konig L, et al
    Motivations, experiences and perspectives of physicians in Germany regarding monitoring routines in coronary heart disease and post-stroke patients: A qualitative interview study.
    PLoS One. 2026;21:e0348530.
    

    >> Share

    
    

    
    Prog Cardiovasc Dis

40. ALEKSOVA A, Janjusevic M, Marketou M, Beltrami AP, et al
    Charting individualized pathways: IGF-1 and vitamin D in guiding personalized medicine for residual risk after AMI.
    Prog Cardiovasc Dis. 2026;96:16-26.
    

    >> Share

    
    
41. MUSCOGIURI G, Guaricci AI, Fusini L, Senatieri A, et al
    CarDiac magnEtic resonance for prophylactic implantable cardioVerter defibrillAtor ThErapy in ischemic dilated CardioMyopathy: Prognostic implication of papillary muscles involvement.
    Prog Cardiovasc Dis. 2026;96:44-51.
    

    >> Share

    
    
42. GALLI S, Ventura E, Genta EO, Mushtaq S, et al
    Advanced CCTA imaging, angiography-based Radial Wall strain and muFR versus IVUS-NIRS to enhance identification of lipid-rich vulnerable plaques: A multimodality imaging approach.
    Prog Cardiovasc Dis. 2026;96:55-64.
    

    >> Share

    
    

    
    Thromb Haemost

43. ASHER E, Taha L, Karmi M, Sabouret P, et al
    Association of Admission Immature Platelet Fraction with Long-Term Mortality Following Primary Percutaneous Coronary Intervention for STEMI.
    Thromb Haemost. 2026 Sep 7. doi: 10.1055/a-2945-5355.
    

    >> Share

    
    
44. ASHER E, Taha L, Karmi M, Brin A, et al
    Immature Platelet Fraction as an Independent Marker of Adverse Outcomes in an Intensive Cardiovascular Care Unit.
    Thromb Haemost. 2026 Sep 11. doi: 10.1055/a-2944-1196.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share